Skip to search formSkip to main contentSkip to account menu

Abnormal involuntary movement

Known as: Abnormal involuntary movements 
National Institutes of Health

Related topics

Related topics

28 relations
AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIABradykinesiaCerebral PalsyCongenital Cerebral Palsy

Narrower (9)

Abnormal head movementsAthetosisChoreaChoreoathetosis

Broader (4)

Brain DiseasesDyskinetic syndromeMovement Disordersnervous system disorder

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats
Highly Cited
2011
Highly Cited
2011
l-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata
Highly Cited
2010
Highly Cited
2010
Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat
Highly Cited
2009
Highly Cited
2009
Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model
Highly Cited
2008
Highly Cited
2008
Continuous and Intermittent Nicotine Treatment Reduces l-3,4-Dihydroxyphenylalanine (l-DOPA)-Induced Dyskinesias in a Rat Model of Parkinson's Disease
The development of abnormal involuntary movements (AIMs) or dyskinesias is a serious complication of l-DOPA [l-3,4… 
2008
2008
Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on l-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat
RationaleSerotonin 1A receptor (5-HT1AR) agonists reduce l-DOPA-induced dyskinesia and enhance motor function in experimental and… 
Highly Cited
2007
Highly Cited
2007
Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model
Highly Cited
2007
Highly Cited
2007
The partial 5-HT1A agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy
Highly Cited
2006
Highly Cited
2006
Role of striatal l‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats
We explored possible differences in the peripheral and central pharmacokinetics of l‐DOPA as a basis for individual variation in… 
Highly Cited
1986
Highly Cited
1986
Dopamine agonist induced self-multilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brainstem: Possible pharmacological model for Lesch-Nyhan syndrome
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)